Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2014 (2014), Article ID 949515, 4 pages
http://dx.doi.org/10.1155/2014/949515
Case Report

Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide

Bagi Jana,1,2,3 Anas Khanfar,1,2 and Mary Ninan1,2,3

1The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA
2Department of Internal Medicine, 301 University Boulevard, Galveston, TX 77555, USA
3Divisions of Hematology and Oncology, 301 University Boulevard, Galveston, TX 77555, USA

Received 10 December 2013; Accepted 31 December 2013; Published 12 February 2014

Academic Editors: K. Jamil and D. Yin

Copyright © 2014 Bagi Jana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Bagi Jana, Anas Khanfar, and Mary Ninan, “Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide,” Case Reports in Oncological Medicine, vol. 2014, Article ID 949515, 4 pages, 2014. doi:10.1155/2014/949515